People struggling with obesity are often fighting biology. That’s why a new class of drugs that includes Ozempic is showing more success than behavioral changes like dieting ever have. The newest drug in this group, Mounjaro, is a diabetes drug that the FDA is evaluating as an obesity treatment. Early results show it takes the benefits of Ozempic up a notch.
New medications, like Wegovy and Ozempic, can boost the effects of these hormones. But how we eat, exercise, and manage stress also play a big role in whether we gain or lose weight.
Clicking on the Facebook, Twitter, Instagram, and National Geographic Channel links will take you away from our National Geographic Partners site where different terms of use and privacy policy apply.
This email was sent to: peter.hovis@gmail.com. Please do not reply to this email as this address is not monitored.
This email contains an advertisement from:
National Geographic | 1145 17th Street, N.W. | Washington, D.C. 20036